Literature DB >> 9187102

Cytological detection of telomerase activity using an in situ telomeric repeat amplification protocol assay.

K Ohyashiki1, J H Ohyashiki, J Nishimaki, K Toyama, Y Ebihara, H Kato, W E Wright, J W Shay.   

Abstract

A previously reported highly sensitive assay for measuring telomerase activity on cell and tissue extracts indicates that most human tumor tissues, but not cells adjacent to tumors, have detectable telomerase activity. Although this assay has provided a significant amount of information about the presence or absence of telomerase activity, it does not indicate whether all cells within a tumor have telomerase activity or whether only a subset does. The present report demonstrates the ability to advance this technology to an in situ assay. Using fluorescent telomerase primers and in situ PCR, we show that telomerase activity can be detected at the cellular level. This study demonstrates that telomerase activity is not detected in normal cells but is detected in tumor cells of clinical specimens and in tumor-derived cell lines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9187102

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  An improvement method for the detection of in situ telomerase activity: in situ telomerase activity labeling.

Authors:  De-Yun Feng; Hui Zheng; Chun-Yan Fu; Rui-Xue Cheng
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

Review 2.  Molecular diagnostic tests in the diagnosis and management of thyroid carcinoma.

Authors:  M D Ringel
Journal:  Rev Endocr Metab Disord       Date:  2000-04       Impact factor: 6.514

3.  Age-related telomere uncapping is associated with cellular senescence and inflammation independent of telomere shortening in human arteries.

Authors:  Richard G Morgan; Stephen J Ives; Lisa A Lesniewski; Richard M Cawthon; Robert H I Andtbacka; R Dirk Noyes; Russell S Richardson; Anthony J Donato
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-05-10       Impact factor: 4.733

4.  Telomerase detection in the diagnosis and prognosis of cancer.

Authors:  Eiso Hiyama; Keiko Hiyama
Journal:  Cytotechnology       Date:  2004-06       Impact factor: 2.058

Review 5.  Biosensor Techniques Used for Determination of Telomerase Activity in Cancer Cells.

Authors:  Eliona Kulla; Evgeny Katz
Journal:  Sensors (Basel)       Date:  2008-01-21       Impact factor: 3.576

6.  Assays for detection of telomerase activity.

Authors:  D A Skvortsov; M E Zvereva; O V Shpanchenko; O A Dontsova
Journal:  Acta Naturae       Date:  2011-01       Impact factor: 1.845

Review 7.  Telomeres and telomerase in endocrine pathology.

Authors:  G Kontogeorgos; K Kovacs
Journal:  Endocrine       Date:  1998-10       Impact factor: 3.925

8.  Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines.

Authors:  O Uziel; E Fenig; J Nordenberg; E Beery; H Reshef; J Sandbank; M Birenbaum; M Bakhanashvili; R Yerushalmi; D Luria; M Lahav
Journal:  Br J Cancer       Date:  2005-05-23       Impact factor: 7.640

9.  Single-molecule real-time detection of telomerase extension activity.

Authors:  Helen Hwang; Patricia Opresko; Sua Myong
Journal:  Sci Rep       Date:  2014-09-29       Impact factor: 4.996

10.  Trend of telomerase activity change during human iPSC self-renewal and differentiation revealed by a quartz crystal microbalance based assay.

Authors:  Yitian Zhou; Ping Zhou; Yinqiang Xin; Jie Wang; Zhiqiang Zhu; Ji Hu; Shicheng Wei; Hongwei Ma
Journal:  Sci Rep       Date:  2014-11-10       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.